Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin

Translated title of the contribution: Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care

Research output: Journal article (peer-reviewed)Journal article

Abstract

Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.

Translated title of the contributionBisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care
Original languageGerman
Pages (from-to)702-706
Number of pages5
JournalWiener Medizinische Wochenschrift
Volume158
Issue number23-24
DOIs
Publication statusPublished - 2008
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care'. Together they form a unique fingerprint.

Cite this